Synthesis and characterization of membranes obtained by graft copolymerization of 2-hydroxyethyl methacrylate and acrylic acid onto chitosan by Santos, K. S. C. R. dos et al.
International Journal of Pharmaceutics 310 (2006) 37–45
Synthesis and characterization of membranes obtained
by graft copolymerization of 2-hydroxyethyl
methacrylate and acrylic acid onto chitosan
K.S.C.R. dos Santos a,b,∗, J.F.J. Coelho b, P. Ferreira b, I. Pinto b,
S.G. Lorenzetti c, E.I. Ferreira a, O.Z. Higa c, M.H. Gil b
a Faculdade de Cieˆncias Farmaceˆuticas, Universidade de Sa˜o Paulo, Av. Prof. Lineu Prestes, 580, Bloco 13, 05508-900 Sa˜o Paulo, Brazil
b Departamento de Engenharia Quı´mica, Faculdade de Cieˆncia e Tecnologia, Universidade de Coimbra,
Polo II, Pinhal de Marrocos, 3030-290 Coimbra, Portugal
c Instituto de Pesquisas Energe´ticas e Nucleares, IPEN/CNEN, Av. Prof. Lineu Prestes, 2242, 05508-900 Sa˜o Paulo, Brazil
Received 26 July 2005; received in revised form 2 November 2005; accepted 3 November 2005
Available online 18 January 2006
A
a
g
h
t
a
©
K
1
a
3
i
d
s
u
d
d
i
a
t
P
i
0
dbstract
Chitosan based membranes to be applied on wound healing as topical drug delivery systems were developed by graft copolymerization of
crylic acid (AA) and 2-hydroxyethyl methacrylate (HEMA) onto chitosan using cerium ammonium nitrate as chemical initiator. Evidence for
raft copolymerization of the vinyl monomers onto chitosan was obtained by FTIR and DMTA. Swelling degree, cytotoxicity, thrombogenicity and
aemolytic activity of these membranes were evaluated. Chitosan-graft-AA-graft-HEMA showed to be the best matrix for drug delivery systems
han chitosan-graft-AA because it retains good swelling properties, but the content in HEMA has improved cytocompatibility, hemocompatibility
nd thrombogenic character.
2005 Elsevier B.V. All rights reserved.
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. Introduction
In the past, wounds were treated by allowing them to dry
nd, hence, acquire a hard protective coating, the scab. About
0 years ago, the treatment of wounds was revolutionized when
t was discovered that a wound would heal faster when a ‘moist’
ressing was applied rather than the traditional ‘dry’ dressings
uch as gauze type materials produced from cotton or lint. Nat-
ral skin is recognized as the ideal wound dressing and so the
evelopment of ‘moist’ dressings was based on the interest on
eveloping substitutes of skin with its 85% water content and
nherent permeability. In this context, wound management aids
re available in a range of physical forms including fibres and
hreads, films for use as a covering and gels (Lloyd et al., 1998).
olysaccharides, as natural biomolecules, are obvious choice for
nvestigation as potential wound substitutes. The polysaccha-
∗ Corresponding author. Tel.: +55 11 3091 3687; fax: +55 11 3815 4418.
E-mail address: katiasol@usp.br (K.S.C.R. dos Santos).
rides and its derivatives may, by themselves, actively participate
in the process of wound healing. As examples, hyaluronic acid
and chitosan can be used for this purpose.
Chitin, the second most abundant natural polysaccharide,
found in the exoskeleton of crustaceous, the cuticles of insects,
and the cell walls of fungi, is a linear homopolymer composed
of (1–4)-linked N-acetyl glucosamine (Li et al., 1997). Par-
tial deacetylation of chitin results in the production of chitosan,
which is a polysaccharide composed by copolymers of glu-
cosamine and N-acetyl glucosamine (Singla and Chawla, 2001).
Chitosan is currently receiving a great deal of attention
for medical and pharmaceutical applications. The main rea-
sons for this are undoubtedly its appealing intrinsic properties,
such as biocompatibility, biodegradability, non-toxicity, adsorp-
tion properties, film-forming ability, bioadhesivity, antimicro-
bial activity against fungi, bacteria and viruses, in addition to
its haemostatic effect (Henriksen et al., 1996; Rao and Sharma,
1997; Illum, 1998; Ravi Kumar, 2000; Chirkov, 2002; Lim and
Hudson, 2003; Okamoto et al., 2003; Rabea et al., 2003; Zheng
and Zhu, 2003). Most of the properties of chitosan can be related
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to its cationic nature. At acidic pH, it is a linear polyelectrolyte
with a high charge density with one positive charge per glu-
cosamine residue and, therefore, will interact with negatively
charged molecules including proteins, anionic polysaccharides
and nucleic acids (Olsen et al., 1988; Lloyd et al., 1998).
As Lloyd et al. (1998) have reported, in the area of wound
healing, chitosan can reduce scar tissue (fibroplasia) by inhibit-
ing the formation of fibrin in wounds. Chitosan can enhance
blood coagulation by an independent mechanism of the classi-
cal coagulation cascade and appear to be an interaction between
negative charges of cell membranes of erythrocytes and pos-
itive charges of chitosan filaments (Rao and Sharma, 1997;
Okamoto et al., 2003). One hypothesis advanced to explain the
ability of chitosan to enhance wound healing is related to its
biodegradability (Berger et al., 2004). Lysozyme, normally pro-
duced by macrophages, hydrolyses chitosan and its derivatives to
oligomers, which activate macrophages to produce nitric oxide,
activated oxygen species, tumor necrosis factor-, interferon
and interleukin-1. Activated macrophages increase the produc-
tion of lysozyme, chitinase and N-acetyl--d-glucosaminidase,
which catalyse the total depolymerization to monomers. The
monomeric aminosugars become available to fibroblasts which
proliferate under the action of interleukin-1, for incorporation
into chondroitin 4- and 6-sulfate, hyaluronan and keratin sulfate,
thus guiding the ordered deposition of collagen and also accel-
erating the wound healing process (Muzzarelli, 1991, 1997). All
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wound dressing due to their content in water (‘moist’ dressing)
and, once membranes can absorb large contents in water, they
are able to retain more drug into their matrix when dried mem-
branes are immersed on drug aqueous solution. Some of previous
studies have shown that the presence of HEMA in copolymers
improves the biocompatibility of these materials (Carenza, 1992;
Singh and Ray, 1994).
2. Material and methods
2.1. Material
Chitosan, with a 0.15 acetylation degree (DA) and a
145,000 viscosimetric molecular weight was purchased from
Aldrich Chemical Company Inc. DA was calculated from
1H RMN in an ADPX 300 MHz spectrometer from Bru¨ker.
The intrinsic viscosity was performed with an AVS-350
viscometer coupled to an AVS-50 automatic dilution module,
both from Schott-Gera¨te. AA, HEMA and cerium ammonium
nitrate were purchased from Aldrich Chemical Company
Inc. Acetic acid, calcium chloride and formaldehyde were
purchased from Merck & Co. Inc. Phosphate buffered saline
pH 7.4 (PBS), RPMI 1640 culture medium, fetal bovine
serum (FBS) and trypsin were purchased from GibcoTM Cell
Culture Products. The corants 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulphophenyl-2H-tetrazolium
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dhese properties, including its bioadhesivity, make chitosan an
xcellent biomaterial to treat wounds and scars.
Modifications on the chitosan structure can be carried out
n order to adequate it to the intended application, such as
ydrosolubility, adhesivity, haemocompatibility and others. The
odification of polymeric materials by graft copolymerization
as been studied deeply by several authors (Kurika, 1996; Harish
rashanth and Tharanathan, 2003; Sashiwa and Aiba, 2004)
ecause it can provide materials with desired properties through
he appropriate choice of the molecular characteristics of the
ide chain to be grafted (Casimiro et al., 2005). Chitosan bears
wo types of reactive groups that can be modified by grafting: the
-2 free amino groups on deacetylated units and the hydroxyl
roups in the C-3 and C-6 either in acetylated or deacetylated
nits (Lloyd et al., 1998; Berger et al., 2004) (Fig. 1). The
eactive amino group in chitosan is important in several targeted-
tructural modifications since the deprotonated amino group
cts as a powerful nucleophile (pKa ∼= 6.3), readily reacting with
lectrophilic reagents (Chen et al., 2000).
The main objective of this study was to obtain membranes for
ounds treatment with dual effects: to accelerate wound healing
ue to the bioactivities of chitosan itself and at the same time the
olymeric matrix should act as a delivery system for many drugs
o prevent or treat bacterial infections. With this purpose, new
aterial was synthesized by grafting vinyl monomers, AA and
EMA, onto chitosan. The poly(AA), which is biocompatible
nd with antibacterial properties, is widely used in adhesives and
uper absorbents materials due to its pendant carboxylic groups
Lee et al., 1999, 2005; Athawale and Lele, 2001). Polymers
rafted by AA become highly hydrophilic materials and inter-
sting matrixes for drug delivery systems. They make a goodMTS) and phenazine methosulfate (PMS) were purchased
rom Promega Corporation.
.2. Graft copolymerization
A 2% (w/v) chitosan stock solution was prepared in 1% (v/v)
cetic acid aqueous solution. Fifteen milliliters of chitosan stock
olution was stirred with 50 mg of cerium ammonium nitrate for
0 min. AA and HEMA monomers, which were used in different
olar rates according to Table 1, were added to this solution and
tirred until complete homogenization. The resulting solutions
ere transferred to Petri dishes and allowed to react for 24 h at
5 ◦C. Resultant films that formed were obtained and removed
rom the Petri dishes by adding 1% sodium hydroxide aqueous
olution. They were extracted in a Soxhlet for a 6 h reflux using
istilled water as a solvent to remove the homopolymer or non-
eacted monomers. Finally, the membranes were dried at room
emperature on Teflon® surfaces.
.3. Infrared analysis
FTIR analysis of grafted chitosan films was performed in
agma – IRTM Spectrometer 750 from Nicolet Instrument Corp.
quipped with Golden Gate Single Reflection Diamond ATR.
.4. Thermal properties
Thick specimens (15.20 mm × 7.45 mm × 1.10 mm) were
nalysed by dynamical mechanical thermal analysis (DMTA).
Triton Tritec 2000 analyser was used in the constrain layer
amping mode, with a standard heating rate of 10 ◦C min−1, at
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Fig. 1. Schematic representation of graft copolymerization of HEMA and AA onto chitosan.
frequency of 1 Hz and a displacement of 0.05 mm. The glass
transition temperature was determined as the peak in tan δ
(tan δ = E′′/E′) where E′′ and E′ are the loss and storage mod-
ulus, respectively, derived from DMTA. All samples were dried
for 24 h at 55 ◦C before thermal analysis.
2.5. Swelling studies
Dried samples (Wd) were immersed in distilled water for
48 h. The swollen samples (Ws) were removed from the solu-
tion, quickly wiped with filter paper and weighed. The maximum
water uptake (Q) of membranes was determined according to the
following expression:
Q =
[
Ws − Wd
Wd
]
· 100
2.6. Haemocompatibility
The haemocompatibility was evaluated in vitro accord-
ing to the International Standard Organization (ISO) (ISO
10993-4, 1999), and the following categories of blood
Table 1
Reactional conditions for synthesis of membranes
Sample chitosan (NH4)2Ce(NO3)6 (mg) HEMA AA
(mmol) (mL)a (mmol) (mL) (mmol) (mL)
M1 1.86 15 – – – – –
M2 1.86 15 50 12 2.92 – –
M3 1.86 15 50 – – 12 1.64
M4 1.86 15 50 6 1.46 6 0.82
a A 2% (w/v) chitosan solution.
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interactions were studied: thrombogenicity and haemolytic
potential.
2.6.1. Thrombogenicity
The evaluation of thrombus formation on polymeric surfaces
was carried out using a gravimetric method (Imai and Nose,
1972). Anticoagulated rabbit blood was used with this purpose.
This sample was prepared by adding 1 mL of anticoagulant acid
citrate dextrose solution (ACD) (US Pharmacopeia XXIII, 1994)
to 9 mL of fresh rabbit blood. Before performing the tests, the
membranes were immersed in PBS at a constant temperature of
37 ◦C. After 48 h of incubation, the PBS was removed and the
ACD blood was put in contact with the surface of the polymers
and also to an empty Petri dish, which acted as a positive control.
Blood clotting tests were initiated by adding 0.02 mL of a 10 M
calcium chloride solution and were stopped after 45 min by the
addition of 5 mL of water. The resultant clots were fixed with
5 mL of a 36% formaldehyde solution and were then dried with
tissue paper and finally weighed.
2.6.2. Haemolytic potential
The haemolysis tests were performed as described in
American Society for Testing and Materials (ASTM) (ASTM F
756-00, 2000). Samples (21 cm2) were placed in polypropylene
test tubes and 7 mL of PBS were added. After 72 h of incubation
at 37 ◦C, the PBS was removed and 1 mL of diluted ACD
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2.7.1. Extract preparation
According to the ISO 10993–5 (1992), the ratio between
the surface area of the material and the volume of extraction
vehicle should be in a range of 0.5 and 6.0 cm2/mL. Hence,
membrane samples of 4 cm2 were sterilized by autoclaving at
120 ◦C for 20 min and then 4 mL of RPMI 1640 containing
10% FBS were added and stationary incubated at 37 ◦C for 2
days. The extract obtained was employed for the cytotoxicity
assay.
2.7.2. Cytotoxicity assay
Chinese hamster ovary (CHO) cells were grown in cul-
ture medium composed of RPMI 1640 containing 10% FBS,
in a plastic tissue culture flask, at 37 ◦C in a humidified
5% CO2 air incubator. After confluent monolayer propaga-
tion, the culture medium was removed and the cells were
washed with PBS. The culture was treated with 0.25% trypsin
solution to detach cells from the culture tissue flask. After
trypsinization, cells were transferred to a screw-capped plas-
tic tube, centrifuged and washed twice with PBS. The cells
were ressuspended in culture medium and the concentration
was adjusted to ∼60,000 cells/mL. Ninety six-well tissue cul-
ture microtiter plates were prepared by the addition of the
biomaterial extract (50L/well in quadruplicate), followed by
the addition of 50L of the cell suspension (∼ 3000 cells).
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1abbit venous blood (9.02 mg/mL) was added to each sample
nd maintained at 37 ◦C for 3 h. Positive and negative controls
ere prepared by adding the same amount of ACD blood to
mL of water and PBS, respectively. Each tube was gently
nverted twice each 30 min to maintain contact of the blood
ith the material. After incubation, each fluid was transferred
o a suitable tube and centrifuged at 2000 rpm for 15 min. The
aemoglobin released by haemolysis was measured by the
ptical densities (OD) of the supernatants at 540 nm using a
pectrophotometer UV–vis (Jasco V-550). The percentage of
aemolysis was calculated as follows
aemolysis(%) =
[ (OD sample − OD negative control)
(OD positive control − OD negative control
According to ASTM F 756-00 (2000) materials can be
lassified in three different categories according to their
aemolytic index (haemolysis%). Materials with percentages
f haemolysis over 5% are considered haemolytic; while the
nes with haemolytic index between 5% and 2% are classified
s slightly haemolytic. Finally, when the material presents
haemolysis percentage below 2% it is considered as a
on-haemolytic material.
.7. Cytotoxicity test
The cytotoxicity assay of the biomaterial was carried out
ccording to ISO 10993–5 (1992). The cell line recommended
y ISO is a preferred established cell line obtained from
ecognized repositories as American Type Culture Collection
ATCC). Chinese hamster ovary cells (ATCC CHO K1) were
sed in this investigation.100
lank was prepared with culture medium without cells and a
egative control was prepared with culture medium instead of
xtract plus cells, both in quadruplicates. Extract solution of
DPE (high density poly(ethylene)) and 0.3% phenol solution
ere assayed such as negative and positive material controls,
espectively. Microplates were incubated in a 5% CO2 humidi-
ed atmosphere. After 72 h, 20L of a mixture (20:1) of 0.2%
TS and 0.09% PMS in PBS were added to the test wells
nd left for 2 h. Incorporated dye was measured by reading
he absorbance at 490 nm in a microplate reader against the
lank.
. Results and discussion
Four different membranes with different compositions were
ynthesized in accordance to the stoichiometry presented in
able 1. The M1 sample is the ungrafted chitosan membrane,
hich corresponds to the control. M2 and M3 samples represent
hitosan membranes grafted with HEMA and AA, respectively.
o prepare M6 sample the vinyl monomers were used together
n the graft reactions at 1:1 molar ratio. The graft copolymer-
zation is a random and heterogeneous process (Fig. 1). Side
hains could be covalently linked to the C-2 free amino groups
n deacetylated units or to the hydroxyl groups in the C-3 and C-
carbons either of acetylated or deacetylated units (Lloyd et al.,
998; Berger et al., 2004). They are formed by the arrangement
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Fig. 2. FTIR aligned spectrums of M1, M2, M3 and M4 samples.
of the HEMA and AA monomers either in blocks or randomly.
Despite these variables, the success of graft copolymerization
reactions was confirmed by FTIR and DMTA.
Fig. 2 represents the FTIR aligned spectra of all samples.
The absorption at 1720 cm−1 is attributed to the C O asymmet-
ric stretching of the ester of poly(HEMA), confirming that M2
and M4 samples were grafted by this polymer. The very intense
characteristic band at 1560 cm−1 is due to the C(O asymmet-
ric stretching of the carboxylate anion from poly(AA) grafted
onto M3 and M4 chitosan membranes. This is reconfirmed by
other sharp peak at 1405 cm−1, which is related to the symmet-
ric stretching mode of the carboxylate anion (Hu et al., 2002;
Mahdavinia et al., 2004). The salt form of the free carboxylic
group is expected since the membranes were neutralized with
sodium hydroxide solution to remove them from the plates. To be
sure there were not residual monomers on membranes, the final
extraction solvent was analysed by UV spectroscopy (data not
shown). No signal was obtained, showing that all the monomers
were already extracted.
The DMTA represents a powerful technique to determine the
miscibility of different compounds, which is an important help
to characterize the graft copolymers based on chitosan, prepared
in this work. We can normally consider that the detection of a
single peak in tan δ is a sufficient criterion to assume the mis-
Fig. 3. DMTA aligned curves of M1, M2, M3 and M4 samples.
cibility, when compounds do not have Tg values too close. It
is important to elucidate whether the polymer blend is miscible
or immiscible, since it plays an important role in the composite
behaviour (Wu et al., 2004).
Fig. 3 represents the DMTA aligned curves of all samples.
The membrane M1 was prepared to obtain the thermal charac-
terization of the chitosan used in this work. For that reason and
in order to obtain additional information about the nature of the
movements involved, the DMTA of this membrane was recorded
at two different frequencies. The results obtained at 1 Hz showed
five important peaks at 0, 72, 131, 201 and at 292 ◦C. The first
peak at 0 ◦C is related with the chain movements induced by
the water presence. The peak at 72 ◦C can be attributed to some
water induced relaxation due to the chitosan hydrophylicity. This
transition can be detected also by DSC for a 5–25% range of
moisture, due to the enthalphic association between water and
the carbohydrate. The second transition at 131 ◦C (Wu et al.,
2004; Mucha and Pawlak, 2005) is normally ascribed to the
glass transition temperature. Concerning the peak at 200 ◦C it
is difficult to recognize it as a consequence of any molecular
movement. Dong and co-workers have reported that the Tg of
chitosan is around 200 ◦C, which is very close to the degrada-
tion temperature onset. One possible justification for the peak at
200 ◦C is some liquid–liquid transition, which corresponds to the
motion of very long segments or even the whole chain (Dong et
al., 2004). According to the results obtained at two different fre-
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muencies (0.316 and 1 Hz) for M1 the only peak that showed to
e frequency dependent was that recognized as the Tg (131 ◦C),
s expected since it represents an alfa-relaxation. For that rea-
on, it is assumed that the Tg of the chitosan used in this work is
31 ◦C. The final peak at 300 ◦C is widely recognized as related
o the decomposition temperature (Jiang et al., 1996; Xiao et al.,
003). It starts generally around 230 ◦C, and can also be con-
rmed by using the thermogravimetric data published (Liu et
l., 2003). The initial temperature for decomposition can also be
eported (slight different values) to the dependence of the acetyl
ontent and the degree of polymerisation, which influences ther-
al stability. A small peak at 350 ◦C was also detected, and most
robably is due to the main chain cleavage.
The M2 curve shows a single and sharp peak in the alfa-
ransition region. This observation allows us to consider a perfect
iscibility between the poly(HEMA) and chitosan. The peak
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that corresponds to the degradation has shifted to higher temper-
atures, which indicates increasing in thermostability. It should
be also referred that the peak around 75 ◦C disappeared, indicat-
ing a different water behaviour in chitosan when poly(HEMA)
is grafted. Another important characteristic of the copolymer
prepared is the lower intensity of the peaks at 0 and 72 ◦C. As
mentioned before, they are related with water induction move-
ments. This fact shows a decrease in the capacity to retain water
due to the introduction of the poly(HEMA). TheM3 curve shows
that the graft copolymer with AA has a higherTg when compared
with the chitosan (M1). This observation is related most prob-
ably with the reaction between amino groups of chitosan and
carboxylic groups of poly(AA) from adjacent chains, resulting
in the formation of a stiffer material. The degradation temper-
ature onset was also shifted to higher temperature showing an
improvement in the chitosan thermal properties. A careful exam-
ination of the behaviour depicted in the degradation curve shows
three regions: a small peak in the region of 240–250 ◦C, due
to water loss caused by the amide formation on the carboxy-
late group in the poly(AA); a second peak between 250 and
320 ◦C due to the deacytelation of chitosan and decarboxyla-
tion of poly(AA) main chains, and the last peak after 320 ◦C
mainly due to chain cleavage of chitosan. In what concerns the
M4 sample, the glass transiton temperature was shifted to higher
temperature compared with poly(AA) and poly(HEMA) them-
selves, 106 ◦C (Kim et al., 2003; Jovanovic et al., 2004) and
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Fig. 4. Swelling degrees (Q) of membranes.
measured in some triplicates reflect the heterogeneity of graft
reactions. Depending on the membrane portion taken for the test,
the results could differ drastically between themselves due to the
random insertion of the vinyl side chain grafted onto chitosan.
This heterogeneous behaviour was also observed in attempts to
determine the hydrophilic character of membrane surfaces by
measurement of the contact angle through pendent water drop
method (data not shown). In so far as films were screened, the
contact angle measurements differed drastically between them-
selves from one point to another, reinforcing the idea of random
graft copolymerization of HEMA and AA onto chitosan.
Since these membranes were designed to be used topically
in wound healing, it is important to evaluate its tissue and
blood compatibility. Furthermore, the thrombogenic character
is a desirable property in membranes. Once the protein adhe-
sion constitutes the first step to initiate the coagulation cascade,
membranes can accelerate the thrombus formation, stopping
haemorrhage and helping in the healing process.
Fig. 5 shows the weights of the blood clots obtained on throm-
bogenicity test. It was observed that clot formation was lower in5 ◦C (Ende and Peppas, 1996), respectively, and to lower tem-
erature compared with chitosan itself, which indicates some
nteraction between all the components. However, a small peak
n 100 ◦C was also detected. This effect could be due to the water
resence.
The chitosan membranes containing only HEMA (M2) tend
o be thicker and have more wrinkles than those composed exclu-
ively of chitosan (M1). Chitosan membranes grafted with AA
M3) are able to absorb large contents of water, and drastically
ncrease the volume, which makes this film very fragile for han-
ling. Swelling properties are important to mimic the skin’s
oisture and to incorporate drugs in the polymeric matrix, how-
ver, too much impairs the physical stability of the membranes.
hus, it is expected that chitosan membranes grafted with both
onomers are able to mix their properties to obtain membranes
ith ideal swelling, mechanical and physical profiles.
The results obtained in swelling studies are shown in Fig. 4.
he DMTA analysis has already shown that introduction of
oly(HEMA) decreases the chitosan capacity to retain water
hereas poly(AA) increases the swelling properties. M3 sam-
le, the membrane with the highest content in AA, showed the
ighest swelling capacity (Q = 2860%), which was about 14-fold
ore water absorbent than that of the control (M1) but it is frag-
le to handle. Conversely, M2, which is the membrane with the
ighest HEMA content, presented the lowest swelling degree
Q = 220%), which was almost the same as that of the control
Q = 223%). Chitosan membrane grafted with equimolar ratio of
EMA and AA (M4) has swelling properties balanced accord-
ng to the composition of each monomer. It is able to absorb
ve-fold more water than chitosan membrane (M1) without
mpairing its physical stability. The large standard deviations Fig. 5. Thrombogenic index obtained for the membranes.
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the membranes than in the control and for this reason, the poly-
mers are classified as non-thrombogenic (Imai and Nose, 1972).
This characteristic is directly related to the hydrophilicity of
the materials. When placed in contact with a hydrophobic sur-
face, proteins adsorb to it in a strong and irreversible way, while
at hydrophilic surfaces proteins adsorb weakly and reversibly
(Changsheng et al., 2003).
This relation between hydrophilicity and thrombosis was
confirmed by the lower value of thrombus weight that was
formed when blood contacted with M3, the most hydrophilic
of all membranes. However, it could be noticed that M4 was
almost so “thrombogenic” as M2, despite its content in AA.
This result shows that it is possible to obtain a chitosan-based
membrane with some hydrophilic character, but without losing
its thrombogenic properties, by mixing HEMA and AA on graft
copolymerization of chitosan.
Fig. 6 represents values of haemolysis obtained for all
membranes. The method is based on measurement of the
haemoglobin released by haemolysis. Haemolysis is regarded as
an especially significant screening test, once it provides quan-
tification of small levels of plasma haemoglobin, which may not
be measurable under in vivo conditions. As reported in literature
(ISO 10993–4 (1999)), it is not possible to define a univer-
sal level of acceptable or unacceptable amounts of haemoly-
sis. Although by definition a blood-compatible material should
be non-haemolytic, in practice several medical devices cause
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chitosan (M4) generates membrane almost non-haemolytic as
is M2 and it has eight-fold improved the haemolytic behaviour
if compared with chitosan grafted just by AA (M3). Over again,
it is clear that the mixture of HEMA and AA in graft copolymer-
ization of chitosan generates membrane with better properties
than those mono-vinyl-grafted.
Determination of cytotoxicity can be either qualitative or
quantitative (ISO 10993–5, 1992). The qualitative evaluation
examines cells microscopically to assess for changes in general
morphology, vacuolization, detachment and cell and membrane
lysis. Quantitative evaluation of cell death, inhibition of cell
growth, cell proliferation or colony formation (Rogero et al.,
2000). In this study, determination of cytotoxicity was performed
by quantitative evaluation of cell viability.
The method is based on the procedure originally developed
by Borefreund and Puerner (1984) for the screening of cyto-
toxic agents, in general, over monolayer cells. This method is
based on the quantitative assessment of surviving viable cells
following exposure to the toxic agent, by incubation with the
supravital dye tetrazolium compound MTS and an electron cou-
pling reagent PMS. MTS is bioreducted by viable cells into a
formazan product that is soluble in tissue culture medium and a
colorimetric analysis of the incorporate dye is performed. The
amount of MTS, the marker of cell viability, taken up by the cell
population, is directly proportional to the number of viable cells
in the culture.
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caemolysis. This means that when such haemolytic effect takes
lace, it is important to make sure that clinical benefits overcome
he risks and that the values of haemolysis are within acceptable
imits.
The ungrafted chitosan sample (M1) follows into the slightly
aemolytic category according to ASTM F 756-00 (2000) while
2, which represents chitosan-graft-HEMA sample can be con-
idered non-haemolytic. This might be due to the change in
urface composition because the blocking of reactive free amino
roups from chitosan by grafting poly(HEMA) at this moieties.
n the other hand, M3 presents a haemolytic character. It could
e noticed that the mixture between AA and HEMA to graft
Fig. 6. Haemolytic index obtained for the membranes.Fig. 7 shows the results of the cytotoxicity test, which can
redict the biocompatibility of the samples. Comparing mem-
ranes with the negative control (HDPE), M1 and M2 could be
onsidered harmless at the cytotoxic point of view. M3 sample
howed a cytotoxic effect over the cells since it caused 60% of
ell death. However, after grafting chitosan with AA and HEMA
M4), the cell viability was almost two-fold improved in com-
arison with the membrane grafted only by AA (M3). As well
s shown on further assays, the cell viability results indicate that
he introduction of some HEMA content in chitosan-graft-AA
s important to improve also this property.
In conclusion, all membranes with AA in their composi-
ion are able to swell, but M4, which are grafted by equimolar
atio of HEMA and AA, keeps good swelling capacity without
ompromising its physical stability. Besides, M4 had improved
Fig. 7. Citotoxicity test of the membranes.
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thrombogenic, non-haemolytic and cytotoxic profiles in compar-
ison withM3because its content in HEMA. All those advantages
make M4 a suitable biomaterial to be applied as a topical drug
delivery system on wound healing. This work showed that is
possible to obtain chitosan membranes grafted both by AA and
HEMA with improved properties than chitosan grafted just by
either AA or HEMA.
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